Shareholding disclosure

Novartis AG

Declared position

4.298%

Threshold

Crossed upwards

Timeline

Published

06.10.2023

Transaction

04.10.2023

Voting rights breakdown

Voting rights acquired4.298%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TANA500013

Beneficial owner

Novartis AG

Declared address

Novartis AG, 4056 Basel

Receipt of shares as a dividend-in-kind in relation to the spin-off of Sandoz from Novartis.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Sandoz Group AG06.10.2023TANA500013

Disclosure summary

Novartis AG disclosed a holding in Sandoz Group AG on the acquisition side, published by SIX Exchange Regulation on 06.10.2023, at 4.298% of voting rights. Notice category: Single shareholder.

Disclosed position

4.298%

Voting rights acquired

Voting rights acquired4.298%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Sandoz Group AG, published on 06.10.2023.

Publication date06.10.2023

Transaction date04.10.2023

Issuing companySandoz Group AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, 4056 Basel

CategorySingle shareholder

Voting rights acquired4.298%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTANA500013

Commercial register

CHE-103.867.266

Registered

Zefix record

Conditions

Receipt of shares as a dividend-in-kind in relation to the spin-off of Sandoz from Novartis.

Source: SIX Exchange Regulation · Publication date: 06.10.2023

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open